Cardiac sympathoexcitation in heart failure

Autonomic Neuroscience: Basic and Clinical

Volumn 175, Issue 1-2, 2013, Pages 76-84

  May, Clive N ^a   Yao, Song T ^a   Booth, Lindsea C ^a   Ramchandra, Rohit ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Angiotensin; Arterial baroreflex; Cardiac sympathetic nerve activity; Cardiopulmonary reflex; Heart failure; Paraventricular nucleus of the hypothalamus; Renal sympathetic nerve activity

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; LOSARTAN; NORADRENALIN; RENIN;

CARDIAC SYMPATHETIC NERVE ACTIVITY; CARDIAC SYMPATHOEXCITATION; DESENSITIZATION; DISEASE COURSE; HEART EJECTION FRACTION; HEART EXCITATION; HEART FAILURE; HUMAN; HYPOTHALAMUS; MUSCULOSKELETAL SYSTEM PARAMETERS; NONHUMAN; NORADRENALIN BLOOD LEVEL; NORADRENALIN RELEASE; PRESSOR RESPONSE; PRESSORECEPTOR REFLEX; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RENIN RELEASE; REVIEW; SYMPATHETIC NERVE; SYMPATHETIC TONE;

ANIMALS; CARDIOVASCULAR PHYSIOLOGICAL PROCESSES; HEART; HEART FAILURE; HUMANS; SYMPATHETIC NERVOUS SYSTEM;

EID: 84877028539     PISSN: 15660702     EISSN: 18727484     Source Type: Journal    
DOI: 10.1016/j.autneu.2012.10.017     Document Type: Review

References (101)

1. Akama H., McGrath B.P., Badoer E. Volume expansion fails to normally activate neural pathways in the brain of conscious rabbits with heart failure. J. Auton. Nerv. Syst. 1998, 73:54-62.
2. Azevedo E.R., Newton G.E., Floras J.S., Parker J.D. Reducing cardiac filling pressure lowers norepinephrine spillover in patients with chronic heart failure. Circulation 2000, 101:2053-2059.
3. Bainbridge F.A. The influence of venous filling upon the rate of the heart. J. Physiol. 1915, 50:65-84.
4. Briest W., Holzl A., Rassler B., Deten A., Leicht M., Baba H.A., Zimmer H.G. Cardiac remodeling after long term norepinephrine treatment in rats. Cardiovasc. Res. 2001, 52:265-273.
5. Chidsey C.A., Harrison D.C., Braunwald E. Augmentation of the plasma nor-epinephrine response to exercise in patients with congestive heart failure. N. Engl. J. Med. 1962, 267:650-654.
6. CIBIS Investigators A randomized trial of beta-blockade in heart failure. The Cardiac Insufficiency Bisoprolol Study (CIBIS). CIBIS Investigators and Committees. Circulation 1994, 90:1765-1773.
7. Clayton S.C., Haack K.K., Zucker I.H. Renal denervation modulates angiotensin receptor expression in the renal cortex of rabbits with chronic heart failure. Am. J. Physiol. Renal Physiol. 2011, 300:F31-F39.
8. CONSENSUS Trial Study Group Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N. Engl. J. Med. 1987, 316:1429-1435.
9. Dampney R.A. Functional organization of central pathways regulating the cardiovascular system. Physiol. Rev. 1994, 74:323-364.
10. Despas F., Detis N., Dumonteil N., Labrunee M., Bellon B., Franchitto N., Galinier M., Senard J.M., Pathak A. Excessive sympathetic activation in heart failure with chronic renal failure: role of chemoreflex activation. J. Hypertens. 2009, 27:1849-1854.
11. Despas F., Lambert E., Vaccaro A., Labrunee M., Franchitto N., Lebrin M., Galinier M., Senard J.M., Lambert G., Esler M., Pathak A. Peripheral chemoreflex activation contributes to sympathetic baroreflex impairment in chronic heart failure. J. Hypertens. 2012, 30:753-760.
12. Dibner-Dunlap M.E., Thames M.D. Baroreflex control of renal sympathetic nerve activity is preserved in heart failure despite reduced arterial baroreceptor sensitivity. Circ. Res. 1989, 65:1526-1535.
13. DiBona G.F., Sawin L.L. Renal nerve activity in conscious rats during volume expansion and depletion. Am. J. Physiol. 1985, 248:F15-F23.
14. DiBona G.F., Sawin L.L. Reflex regulation of renal nerve activity in cardiac failure. Am. J. Physiol. 1994, 266:R27-R39.
15. DiBona G.F., Sawin L.L. Increased renal nerve activity in cardiac failure: arterial vs. cardiac baroreflex impairment. Am. J. Physiol. 1995, 268:R112-R116.
16. DiBona G.F., Jones S.Y., Brooks V.L. ANG II receptor blockade and arterial baroreflex regulation of renal nerve activity in cardiac failure. Am. J. Physiol. 1995, 269:R1189-1196.
17. Ding Y., Li Y.L., Schultz H.D. Role of blood flow in carotid body chemoreflex function in heart failure. J. Physiol. 2011, 589:245-258.
18. Eckberg D.L., Drabinsky M., Braunwald E. Defective cardiac parasympathetic control in patients with heart disease. N. Engl. J. Med. 1971, 285:877-883.
19. Felder R.B., Francis J., Weiss R.M., Zhang Z.H., Wei S.G., Johnson A.K. Neurohumoral regulation in ischemia-induced heart failure. Role of the forebrain. Ann. N. Y. Acad. Sci. 2001, 940:444-453.
20. Floras J.S. Arterial baroreceptor and cardiopulmonary reflex control of sympathetic outflow in human heart failure. Ann. N. Y. Acad. Sci. 2001, 940:500-513.
21. Franchitto N., Despas F., Labrunee M., Roncalli J., Boveda S., Galinier M., Senard J.M., Pathak A. Tonic chemoreflex activation contributes to increased sympathetic nerve activity in heart failure-related anemia. Hypertension 2010, 55:1012-1017.
22. Francis J., Weiss R.M., Wei S.G., Johnson A.K., Beltz T.G., Zimmerman K., Felder R.B. Central mineralocorticoid receptor blockade improves volume regulation and reduces sympathetic drive in heart failure. Am. J. Physiol. Heart Circ. Physiol. 2001, 281:H2241-H2251.
23. Francis J., Wei S.G., Weiss R.M., Beltz T., Johnson A.K., Felder R.B. Forebrain-mediated adaptations to myocardial infarction in the rat. Am. J. Physiol. Heart Circ. Physiol. 2002, 282:H1898-H1906.
24. Francis J., Wei S.G., Weiss R.M., Felder R.B. Brain angiotensin-converting enzyme activity and autonomic regulation in heart failure. Am. J. Physiol. Heart Circ. Physiol. 2004, 287:H2138-2146.
25. Frithiof R., Ramchandra R., Hood S.G., May C.N. Hypertonic sodium resuscitation after hemorrhage improves hemodynamic function by stimulating cardiac, but not renal, sympathetic nerve activity. Am. J. Physiol. Heart Circ. Physiol. 2011, 300:H685-H692.
26. Gao L., Wang W., Li Y.L., Schultz H.D., Liu D., Cornish K.G., Zucker I.H. Sympathoexcitation by central ANG II: roles for AT1 receptor upregulation and NAD(P)H oxidase in RVLM. Am. J. Physiol. Heart Circ. Physiol. 2005, 288:H2271-H2279.
27. Gao L., Wang W.Z., Wang W., Zucker I.H. Imbalance of angiotensin type 1 receptor and angiotensin II type 2 receptor in the rostral ventrolateral medulla: potential mechanism for sympathetic overactivity in heart failure. Hypertension 2008, 52:708-714.
28. Gao L., Li Y., Schultz H.D., Wang W.Z., Wang W., Finch M., Smith L.M., Zucker I.H. Downregulated Kv4.3 expression in the RVLM as a potential mechanism for sympathoexcitation in rats with chronic heart failure. Am. J. Physiol. Heart Circ. Physiol. 2010, 298:H945-H955.
29. Garg R., Yusuf S. Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. Collaborative Group on ACE Inhibitor Trials. JAMA 1995, 273:1450-1456.
30. Gohlke P., Kox T., Jurgensen T., von Kugelgen S., Rascher W., Unger T., Culman J. Peripherally applied candesartan inhibits central responses to angiotensin II in conscious rats. Naunyn Schmiedeberg's Arch. Pharmacol. 2002, 365:477-483.
31. Grassi G., Seravalle G., Cattaneo B.M., Lanfranchi A., Vailati S., Giannattasio C., Del Bo A., Sala C., Bolla G.B., Pozzi M. Sympathetic activation and loss of reflex sympathetic control in mild congestive heart failure. Circulation 1995, 92:3206-3211.
32. Hasking G.J., Esler M.D., Jennings G.L., Burton D., Johns J.A., Korner P.I. Norepinephrine spillover to plasma in patients with congestive heart failure: evidence of increased overall and cardiorenal sympathetic nervous activity. Circulation 1986, 73:615-621.
33. Hirooka Y., Shigematsu H., Kishi T., Kimura Y., Ueta Y., Takeshita A. Reduced nitric oxide synthase in the brainstem contributes to enhanced sympathetic drive in rats with heart failure. J. Cardiovasc. Pharmacol. 2003, 42(Suppl. 1):S111-S115.
34. Kang Y.M., Zhang Z.H., Johnson R.F., Yu Y., Beltz T., Johnson A.K., Weiss R.M., Felder R.B. Novel effect of mineralocorticoid receptor antagonism to reduce proinflammatory cytokines and hypothalamic activation in rats with ischemia-induced heart failure. Circ. Res. 2006, 99:758-766.
35. Kannan H., Hayashida Y., Yamashita H. Increase in sympathetic outflow by paraventricular nucleus stimulation in awake rats. Am. J. Physiol. 1989, 256:R1325-R1330.
36. Kar S., Gao L., Belatti D.A., Curry P.L., Zucker I.H. Central angiotensin (1-7) enhances baroreflex gain in conscious rabbits with heart failure. Hypertension 2011, 58:627-634.
37. Karim F., Kidd C., Malpus C.M., Penna P.E. The effects of stimulation of the left atrial receptors on sympathetic efferent nerve activity. J. Physiol. 1972, 227:243-260.
38. Kasama S., Toyama T., Kumakura H., Takayama Y., Ichikawa S., Suzuki T., Kurabayashi M. Effects of candesartan on cardiac sympathetic nerve activity in patients with congestive heart failure and preserved left ventricular ejection fraction. J. Am. Coll. Cardiol. 2005, 45:661-667.
39. Kasama S., Toyama T., Hatori T., Sumino H., Kumakura H., Takayama Y., Ichikawa S., Suzuki T., Kurabayashi M. Comparative effects of valsartan and enalapril on cardiac sympathetic nerve activity and plasma brain natriuretic peptide in patients with congestive heart failure. Heart 2006, 92:625-630.
40. Kasama S., Toyama T., Sumino H., Kumakura H., Takayama Y., Minami K., Ichikawa S., Matsumoto N., Sato Y., Kurabayashi M. Effects of mineralocorticoid receptor antagonist spironolactone on cardiac sympathetic nerve activity and prognosis in patients with chronic heart failure. Int. J. Cardiol. 2012, (Jan 13) (Electronic publication ahead of print, PMID: 22245478).
41. Kaye D.M., Lambert G.W., Lefkovits J., Morris M., Jennings G., Esler M.D. Neurochemical evidence of cardiac sympathetic activation and increased central nervous system norepinephrine turnover in severe congestive heart failure. J. Am. Coll. Cardiol. 1994, 23:570-578.
42. Kaye D.M., Lefkovits J., Jennings G.L., Bergin P., Broughton A., Esler M.D. Adverse consequences of high sympathetic nervous activity in the failing human heart. J. Am. Coll. Cardiol. 1995, 26:1257-1263.
43. Kaye D.M., Jennings G.L., Dart A.M., Esler M.D. Differential effect of acute baroreceptor unloading on cardiac and systemic sympathetic tone in congestive heart failure. J. Am. Coll. Cardiol. 1998, 31:583-587.
44. Kitzman D.W., Little W.C., Brubaker P.H., Anderson R.T., Hundley W.G., Marburger C.T., Brosnihan B., Morgan T.M., Stewart K.P. Pathophysiological characterization of isolated diastolic heart failure in comparison to systolic heart failure. JAMA 2002, 288:2144-2150.
45. Kollai M., Koizumi K. Reciprocal and non-reciprocal action of the vagal and sympathetic nerves innervating the heart. J. Auton. Nerv. Syst. 1979, 1:33-52.
46. Leimbach W.N., Wallin B.G., Victor R.G., Aylward P.E., Sundlof G., Mark A.L. Direct evidence from intraneural recordings for increased central sympathetic outflow in patients with heart failure. Circulation 1986, 73:913-919.
47. Levy D., Kenchaiah S., Larson M.G., Benjamin E.J., Kupka M.J., Ho K.K., Murabito J.M., Vasan R.S. Long-term trends in the incidence of and survival with heart failure. N. Engl. J. Med. 2002, 347:1397-1402.
48. Li Y.F., Patel K.P. Paraventricular nucleus of the hypothalamus and elevated sympathetic activity in heart failure: the altered inhibitory mechanisms. Acta physiologica Scandinavica 2003, 177:17-26.
49. Li Y.F., Cornish K.G., Patel K.P. Alteration of NMDA NR1 receptors within the paraventricular nucleus of hypothalamus in rats with heart failure. Circ. Res. 2003, 93:990-997.
50. Li Y.L., Li Y.F., Liu D., Cornish K.G., Patel K.P., Zucker I.H., Channon K.M., Schultz H.D. Gene transfer of neuronal nitric oxide synthase to carotid body reverses enhanced chemoreceptor function in heart failure rabbits. Circ. Res. 2005, 97:260-267.
51. Li Y.L., Xia X.H., Zheng H., Gao L., Li Y.F., Liu D., Patel K.P., Wang W., Schultz H.D. Angiotensin II enhances carotid body chemoreflex control of sympathetic outflow in chronic heart failure rabbits. Cardiovasc. Res. 2006, 71:129-138.
52. Liang C., Rounds N.K., Dong E., Stevens S.Y., Shite J., Qin F. Alterations by norepinephrine of cardiac sympathetic nerve terminal function and myocardial beta-adrenergic receptor sensitivity in the ferret: normalization by antioxidant vitamins. Circulation 2000, 102:96-103.
53. Liu J.L., Murakami H., Sanderford M., Bishop V.S., Zucker I.H. ANG II and baroreflex function in rabbits with CHF and lesions of the area postrema. Am. J. Physiol. 1999, 277:H342-H350.
54. Liu J.L., Irvine S., Reid I.A., Patel K.P., Zucker I.H. Chronic exercise reduces sympathetic nerve activity in rabbits with pacing-induced heart failure: A role for angiotensin II. Circulation 2000, 102:1854-1862.
55. Liu J.L., Pliquett R.U., Brewer E., Cornish K.G., Shen Y.T., Zucker I.H. Chronic endothelin-1 blockade reduces sympathetic nerve activity in rabbits with heart failure. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2001, 280:R1906-R1913.
56. Lovick T.A., Malpas S., Mahony M.T. Renal vasodilatation in response to acute volume load is attenuated following lesions of parvocellular neurones in the paraventricular nucleus in rats. J. Auton. Nerv. Syst. 1993, 43:247-255.
57. Matsukawa K., Ninomiya I., Nishiura N. Effects of anesthesia on cardiac and renal sympathetic nerve activities and plasma catecholamines. Am. J. Physiol. 1993, 265:R792-R797.
58. May C.N., McAllen R.M. Baroreceptor-independent renal nerve inhibition by intracerebroventricular angiotensin II in conscious sheep. Am. J. Physiol. 1997, 273:R560-R567.
59. McConnell P.I., Olson C.E., Patel K.P., Blank D.U., Olivari M.T., Gallagher K.P., Quenby-Brown E., Zucker I.H. Chronic endothelin blockade in dogs with pacing-induced heart failure: possible modulation of sympathoexcitation. J. Card. Fail. 2000, 6:56-65.
60. Meredith I.T., Eisenhofer G., Lambert G.W., Dewar E.M., Jennings G.L., Esler M.D. Cardiac sympathetic nervous activity in congestive heart failure. Evidence for increased neuronal norepinephrine release and preserved neuronal uptake. Circulation 1993, 88:136-145.
61. Miki K., Hayashida Y., Shiraki K. Cardiac-renal-neural reflex plays a major role in natriuresis induced by left atrial distension. Am. J. Physiol. 1993, 264:R369-R375.
62. Morita H., Vatner S.F. Effects of volume expansion on renal nerve activity, renal blood flow, and sodium and water excretion in conscious dogs. Am. J. Physiol. 1985, 249:F680-F687.
63. Newton G.E., Parker J.D. Cardiac sympathetic responses to acute vasodilation. Normal ventricular function versus congestive heart failure. Circulation 1996, 94:3161-3167.
64. Ninomiya I., Matsukawa K., Nishiura N. Central and baroreflex control of sympathetic nerve activity to the heart and kidney in a daily life of the cat. Clin. Exp. Hypertens. A 1988, 10(Suppl. 1):19-31.
65. Packer M., Bristow M.R., Cohn J.N., Colucci W.S., Fowler M.B., Gilbert E.M., Shusterman N.H. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group. N. Engl. J. Med. 1996, 334:1349-1355.
66. Patel K.P. Role of paraventricular nucleus in mediating sympathetic outflow in heart failure. Heart Fail. Rev. 2000, 5:73-86.
67. Patel K.P., Zhang P.L., Carmines P.K. Neural influences on renal responses to acute volume expansion in rats with heart failure. Am. J. Physiol. 1996, 271:H1441-H1448.
68. Petersson M., Friberg P., Eisenhofer G., Lambert G., Rundqvist B. Long-term outcome in relation to renal sympathetic activity in patients with chronic heart failure. Eur. Heart J. 2005, 26:906-913.
69. Pfeffer M.A., Braunwald E., Moye L.A., Basta L., Brown E.J., Cuddy T.E., Davis B.R., Geltman E.M., Goldman S., Flaker G.C., et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. N. Engl. J. Med. 1992, 327:669-677.
70. Polidori C., Ciccocioppo R., Nisato D., Cazaubon C., Massi M. Evaluation of the ability of irbesartan to cross the blood-brain barrier following acute intragastric treatment. Eur. J. Pharmacol. 1998, 352:15-21.
71. Ponikowski P., Chua T.P., Piepoli M., Ondusova D., Webb-Peploe K., Harrington D., Anker S.D., Volterrani M., Colombo R., Mazzuero G., Giordano A., Coats A.J. Augmented peripheral chemosensitivity as a potential input to baroreflex impairment and autonomic imbalance in chronic heart failure. Circulation 1997, 96:2586-2594.
72. Ramchandra R., Hood S.G., Watson A.M., May C.N. Responses of cardiac sympathetic nerve activity to changes in circulating volume differ in normal and heart failure sheep. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2008, 295:R719-R726.
73. Ramchandra R., Hood S.G., Denton D.A., Woods R.L., McKinley M.J., McAllen R.M., May C.N. Basis for the preferential activation of cardiac sympathetic nerve activity in heart failure. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:924-928.
74. Ramchandra R., Hood S.G., Frithiof R., May C.N. Discharge properties of cardiac and renal sympathetic nerves and their impaired responses to changes in blood volume in heart failure. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2009, 297:R665-R674.
75. Ramchandra R., Watson A.M., Hood S.G., May C.N. Response of cardiac sympathetic nerve activity to intravenous irbesartan in heart failure. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2010, 298:R1056-R1060.
76. Ramchandra R., Hood S.G., Watson A.M., Allen A.M., May C.N. Central angiotensin type 1 receptor blockade decreases cardiac but not renal sympathetic nerve activity in heart failure. Hypertension 2012, 59:634-641.
77. Ramchandra R., Hood S., Frithiof R., McKinley M.J., May C.N. The Role of the Paraventricular Nucleus of the Hypothalamus in the Regulation of Cardiac and Renal Sympathetic Nerve Activity in Conscious Normal and Heart Failure Sheep. J. Physiol. 2012, (Jul 2) (Electronic publication ahead of print, PMID: 22615431).
78. Roger V.L., Go A.S., Lloyd-Jones D.M., Benjamin E.J., Berry J.D., Borden W.B., Bravata D.M., Dai S., Ford E.S., Fox C.S., Fullerton H.J., Gillespie C., Hailpern S.M., Heit J.A., Howard V.J., Kissela B.M., Kittner S.J., Lackland D.T., Lichtman J.H., Lisabeth L.D., Makuc D.M., Marcus G.M., Marelli A., Matchar D.B., Moy C.S., Mozaffarian D., Mussolino M.E., Nichol G., Paynter N.P., Soliman E.Z., Sorlie P.D., Sotoodehnia N., Turan T.N., Virani S.S., Wong N.D., Woo D., Turner M.B. Heart disease and stroke statistics-2012 update: a report from the American Heart Association. Circulation 2012, 125:e2-e220.
79. Ros M., Azevedo E.R., Newton G.E., Parker J.D. Effects of nitroprusside on cardiac norepinephrine spillover and isovolumic left ventricular relaxation in the normal and failing human left ventricle. Can. J. Cardiol. 2002, 18:1211-1216.
80. Rundqvist B., Elam M., Bergmann-Sverrisdottir Y., Eisenhofer G., Friberg P. Increased cardiac adrenergic drive precedes generalized sympathetic activation in human heart failure. Circulation 1997, 95:169-175.
81. Stewart S., MacIntyre K., Hole D.J., Capewell S., McMurray J.J. More 'malignant' than cancer? Five-year survival following a first admission for heart failure. Eur. J. Heart Fail. 2001, 3:315-322.
82. Sun S.Y., Wang W., Zucker I.H., Schultz H.D. Enhanced peripheral chemoreflex function in conscious rabbits with pacing-induced heart failure. J. Appl. Physiol. 1999, 86:1264-1272.
83. Swedberg K., Kjekshus J. Effects of enalapril on mortality in severe congestive heart failure: results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). Am. J. Cardiol. 1988, 62:60A-66A.
84. Tan J., Wang H., Leenen F.H. Increases in brain and cardiac AT1 receptor and ACE densities after myocardial infarct in rats. Am. J. Physiol. Heart Circ. Physiol. 2004, 286:H1665-H1671.
85. Thomas J.A., Marks B.H. Plasma norepinephrine in congestive heart failure. Am. J. Cardiol. 1978, 41:233-243.
86. Tsuchiyama Y., Kasamatsu K., Hano T., Nishio I. Acute effect of endothelin AB antagonist on sympathetic outflow in conscious rats with heart failure. Circ. J. 2002, 66:841-845.
87. Vahid-Ansari F., Leenen F.H. Pattern of neuronal activation in rats with CHF after myocardial infarction. Am. J. Physiol. 1998, 275:H2140-H2146.
88. van de Borne P., Oren R., Anderson E.A., Mark A.L., Somers V.K. Tonic chemoreflex activation does not contribute to elevated muscle sympathetic nerve activity in heart failure. Circulation 1996, 94:1325-1328.
89. Wang W., Ma R. Cardiac sympathetic afferent reflexes in heart failure. Heart Fail. Rev. 2000, 5:57-71.
90. Wang Y., Patel K.P., Cornish K.G., Channon K.M., Zucker I.H. nNOS gene transfer to RVLM improves baroreflex function in rats with chronic heart failure. Am. J. Physiol. Heart Circ. Physiol. 2003, 285:H1660-H1667.
91. Watson A.M., Mogulkoc R., McAllen R.M., May C.N. Stimulation of cardiac sympathetic nerve activity by central angiotensinergic mechanisms in conscious sheep. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2004, 286:R1051-R1056.
92. Watson A.M., Hood S.G., Ramchandra R., McAllen R.M., May C.N. Increased cardiac sympathetic nerve activity in heart failure is not due to desensitization of the arterial baroreflex. Am. J. Physiol. Heart Circ. Physiol. 2007, 293:H798-H804.
93. Woodley S.L., Gilbert E.M., Anderson J.L., O'Connell J.B., Deitchman D., Yanowitz F.G., Mealey P.C., Volkman K., Renlund D.G., Menlove R., et al. Beta-blockade with bucindolol in heart failure caused by ischemic versus idiopathic dilated cardiomyopathy. Circulation 1991, 84:2426-2441.
94. Yarbrough W.M., Spinale F.G. Large animal models of congestive heart failure: a critical step in translating basic observations into clinical applications. J. Nucl. Cardiol. 2003, 10:77-86.
95. Yoshimura R., Sato T., Kawada T., Shishido T., Inagaki M., Miyano H., Nakahara T., Miyashita H., Takaki H., Tatewaki T., Yanagiya Y., Sugimachi M., Sunagawa K. Increased brain angiotensin receptor in rats with chronic high-output heart failure. J. Card. Fail. 2000, 6:66-72.
96. Zhang K., Li Y.F., Patel K.P. Reduced endogenous GABA-mediated inhibition in the PVN on renal nerve discharge in rats with heart failure. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2002, 282:R1006-1015.
97. Zhang Z.H., Francis J., Weiss R.M., Felder R.B. The renin-angiotensin-aldosterone system excites hypothalamic paraventricular nucleus neurons in heart failure. Am. J. Physiol. Heart Circ. Physiol. 2002, 283:H423-H433.
98. Zheng H., Li Y.F., Wang W., Patel K.P. Enhanced angiotensin-mediated excitation of renal sympathetic nerve activity within the paraventricular nucleus of anesthetized rats with heart failure. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2009, 297:R1364-1374.
99. Zhu G.Q., Zucker I.H., Wang W. Central AT1 receptors are involved in the enhanced cardiac sympathetic afferent reflex in rats with chronic heart failure. Basic Res. Cardiol. 2002, 97:320-326.
100. Zucker I.H., Gorman A.J., Cornish K.G., Lang M. Imparied atrial receptor modulation or renal nerve activity in dogs with chronic volume overload. Cardiovasc. Res. 1985, 19:411-418.
101. Zucker I.H., Patel K.P., Schultz H.D. Neurohumoral stimulation. Heart Fail. Clin. 2012, 8:87-99.